FDA-Drug2020-03-11Class II
Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 40 mcg/25 mg/0.5mg/0.01mg/ml, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0549-2
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical
Hazard
Lack of Assurance of Sterility
Sold states
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic
Affected count
N/A
Manufactured in
1990 Westwood Blvd Ste 135, N/A, Los Angeles, CA, United States
Products
Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 40 mcg/25 mg/0.5mg/0.01mg/ml, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0549-2
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0933-2020Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief